Pech T et al. |
Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats. |
2012 |
Transplantation |
pmid:22167049
|
Dresske B et al. |
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation. |
2003 |
Transplantation |
pmid:12717217
|
Eason JD et al. |
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. |
2003 |
Transplantation |
pmid:12717237
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Neylan JF |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9500626
|
Hougardy JM et al. |
The once-daily formulation of tacrolimus: a step forward in kidney transplantation? |
2012 |
Transplantation |
pmid:22234346
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
D'Antiga L et al. |
Late cellular rejection in paediatric liver transplantation: aetiology and outcome. |
2002 |
Transplantation |
pmid:11792983
|
Deuse T et al. |
The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent. |
2004 |
Transplantation |
pmid:15084926
|
Ferraris JR et al. |
Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. |
2004 |
Transplantation |
pmid:15084930
|
Shapiro R et al. |
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10628763
|
Andrés A et al. |
A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration. |
2009 |
Transplantation |
pmid:19898206
|
Winkler ME et al. |
Successful pregnancy in a patient after liver transplantation maintained on FK 506. |
1993 |
Transplantation |
pmid:7506460
|
Suzuki S et al. |
Pure red cell aplasia induced by FK506. |
1996 |
Transplantation |
pmid:8607191
|
Busuttil RW et al. |
General guidelines for the use of tacrolimus in adult liver transplant patients. |
1996 |
Transplantation |
pmid:8607197
|
Xu X et al. |
FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. |
2002 |
Transplantation |
pmid:12085010
|
Cassuto E et al. |
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. |
2016 |
Transplantation |
pmid:27653227
|
Saliba F et al. |
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study. |
2016 |
Transplantation |
pmid:27454919
|
Jin S et al. |
Effect of tacrolimus on the expression of macrophage scavenger and nuclear hormone receptors in THP-1-derived human macrophages. |
2004 |
Transplantation |
pmid:15114099
|
Gregory CR et al. |
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. |
1995 |
Transplantation |
pmid:7533955
|
Straatman LP and Coles JG |
Pediatric utilization of rapamycin for severe cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10949201
|
Burke GW et al. |
Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. |
1999 |
Transplantation |
pmid:10573073
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Suzuki S et al. |
Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7685932
|
Moffatt SD et al. |
STAT 6 up-regulation by FK506 in the presence of interleukin-4. |
2000 |
Transplantation |
pmid:10798785
|
Augustine JJ et al. |
Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients. |
2006 |
Transplantation |
pmid:16612276
|
Meier M et al. |
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. |
2006 |
Transplantation |
pmid:16612281
|
Strumph P et al. |
The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. |
1995 |
Transplantation |
pmid:7542815
|
Stempfle HU et al. |
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. |
2002 |
Transplantation |
pmid:11889427
|
Brunet M et al. |
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16495801
|
Chen H et al. |
Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. |
2000 |
Transplantation |
pmid:10836361
|
Hougardy JM et al. |
Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. |
2011 |
Transplantation |
pmid:21192316
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Vanrenterghem Y et al. |
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. |
2004 |
Transplantation |
pmid:15257032
|
Bayés B et al. |
Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. |
2004 |
Transplantation |
pmid:15257035
|
Arai K et al. |
Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival. |
1989 |
Transplantation |
pmid:2479130
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Wang X et al. |
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. |
2005 |
Transplantation |
pmid:15940043
|
Gaber AO et al. |
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. |
2013 |
Transplantation |
pmid:23715050
|
Markus PM et al. |
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. |
1991 |
Transplantation |
pmid:1718063
|
Wiesner RH |
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. |
1998 |
Transplantation |
pmid:9734494
|
Uchida J et al. |
Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients. |
2014 |
Transplant. Proc. |
pmid:24656005
|
Lemmens HP et al. |
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis. |
1994 |
Transplant. Proc. |
pmid:7527983
|
Propper DJ et al. |
Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens. |
1993 |
Transplant. Proc. |
pmid:7679837
|
Jain AB et al. |
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721270
|
Okamura N et al. |
Enhanced liver regeneration by FK 506 can be blocked by interleukin-1 alpha and interleukin-2. |
1992 |
Transplant. Proc. |
pmid:1371624
|
Jin MB et al. |
Protective effect of FK 506 on hepatic energy metabolism in warm ischemic canine livers induced by total hepatic vascular exclusion. |
1996 |
Transplant. Proc. |
pmid:8623243
|
Zervos XA et al. |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636568
|
Tsang WK et al. |
Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients. |
2000 |
Transplant. Proc. |
pmid:11119921
|
Stringa P et al. |
Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice. |
2013 Jul-Aug |
Transplant. Proc. |
pmid:23953566
|
Osuna A et al. |
Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age. |
2005 |
Transplant. Proc. |
pmid:15866630
|
Pascual J et al. |
Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study. |
2005 |
Transplant. Proc. |
pmid:16386527
|
Merli M et al. |
Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. |
2010 |
Transplant. Proc. |
pmid:20534292
|
Uchida H et al. |
Chronopharmacology of tacrolimus in rats: toxicity and efficacy in a mouse-to-rat intestinal transplant model and its pharmacokinetic profile. |
1999 |
Transplant. Proc. |
pmid:10578276
|
Vincenti F et al. |
Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. |
2005 |
Transplant. Proc. |
pmid:15848604
|
DemirbaÅŸ A et al. |
Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. |
2004 Jan-Feb |
Transplant. Proc. |
pmid:15013338
|
Fan Y et al. |
Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. |
2009 |
Transplant. Proc. |
pmid:19545736
|
Platz KP et al. |
FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation. |
1997 |
Transplant. Proc. |
pmid:9365598
|
Gozdowska J et al. |
Tolerance of enteric-coated mycophenolate sodium in combination with calcineurin inhibitor in kidney transplant recipients: Polish experience. |
2011 |
Transplant. Proc. |
pmid:21996197
|
Shibutani S et al. |
FK 506 abrogates induction of regulatory cells after intratracheal delivery of alloantigen. |
2002 |
Transplant. Proc. |
pmid:12176432
|
Lee TK et al. |
Bacterial translocation and the role of postoperative selective bowel decontamination in small intestinal transplantation. |
1994 |
Transplant. Proc. |
pmid:7518154
|
Santiago SF et al. |
Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376520
|
Tanaka M et al. |
Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation. |
1995 |
Transplant. Proc. |
pmid:7533392
|
Winkler M et al. |
Use of FK 506 for treatment of chronic rejection after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721334
|
Hasegawa A et al. |
Improvement of quality of life in tacrolimus-based pediatric renal transplant recipients and their caregivers, including donors. |
2005 |
Transplant. Proc. |
pmid:15919461
|
Ciftci HS et al. |
Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism. |
2017 |
Transplant. Proc. |
pmid:28340819
|
Rodrigues N et al. |
Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study. |
2017 |
Transplant. Proc. |
pmid:28457398
|
Kamei T et al. |
Established intraportal islet allograft is rejected despite the acceptance of donor-specific second cardiac allograft. |
1992 |
Transplant. Proc. |
pmid:1281579
|
Park CS et al. |
Tetrahydrocurcumin Ameliorates Tacrolimus-Induced Nephrotoxicity Via Inhibiting Apoptosis. |
2018 |
Transplant. Proc. |
pmid:30401411
|
Ko WJ et al. |
Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506. |
1998 |
Transplant. Proc. |
pmid:9838474
|
Offner G et al. |
FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up. |
1991 |
Transplant. Proc. |
pmid:1721366
|
Jabiry-Zieniewicz Z et al. |
Outcome of four high-risk pregnancies in female liver transplant recipients on tacrolimus immunosuppression. |
2006 Jan-Feb |
Transplant. Proc. |
pmid:16504718
|
Imai K et al. |
Histopathological study of canine pancreaticoduodenal allotransplantation with FK506, cyclosporine, and triple regimen immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703347
|
Moreno JM et al. |
Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12962831
|
Cho JH et al. |
Chronic rejection in pediatric liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123078
|
Spada M et al. |
Bacterial translocation is enhanced in pig intestinal transplantation when the colon is included in the graft. |
1996 |
Transplant. Proc. |
pmid:8907997
|
Shapiro R et al. |
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176521
|
Townamchai N et al. |
A Simple Novel Technique to Estimate Tacrolimus Dosages During the Early Post Kidney Transplantation Period. |
2015 |
Transplant. Proc. |
pmid:26518946
|
Masaki Y et al. |
Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts. |
1995 |
Transplant. Proc. |
pmid:7536972
|
Klupp J et al. |
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083497
|
Sakamoto K et al. |
Analysis of long-term acceptance of xenografts in rats induced by short-term administration of FK506. |
1989 |
Transplant. Proc. |
pmid:2468222
|
Saracino A et al. |
Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation. |
2014 |
Transplant. Proc. |
pmid:25242754
|
Adibelli Z et al. |
An unusual presentation of sirolimus associated cough in a renal transplant recipient. |
2007 |
Transplant. Proc. |
pmid:18089408
|
Zaltzman J et al. |
Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267183
|
de Bruin RW et al. |
Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation. |
1991 |
Transplant. Proc. |
pmid:1721429
|
Kawabe A et al. |
Anti-adhesion (anti-ICAM-1 and anti-LFA-1) therapy in a rat pancreas transplantation model. |
1996 |
Transplant. Proc. |
pmid:8658893
|
Goto T et al. |
Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. |
1987 |
Transplant. Proc. |
pmid:2445072
|
Burrows L et al. |
Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9723378
|
Fuchs U et al. |
Clinical outcome in cardiac transplant recipients receiving tacrolimus retard. |
2013 |
Transplant. Proc. |
pmid:23769094
|
Cintra-Cabrera M et al. |
Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review. |
2018 |
Transplant. Proc. |
pmid:29579856
|
Kim SH et al. |
Outcomes of Early Conversion From Prograf to Generic Tacrolimus in Adult Living Donor Liver Transplant Recipients. |
|
Transplant. Proc. |
pmid:26293073
|
Shi G et al. |
Variation of CD4CD25Foxp3 Regulatory T Cells and Th17 Cells in the Peripheral Blood of Human Liver Allograft Patients With Long-term Survival. |
2017 |
Transplant. Proc. |
pmid:28923634
|
McAlister VC |
Liposomal tacrolimus: drug migration within blood compartments. |
1998 |
Transplant. Proc. |
pmid:9636404
|
Hesse CJ et al. |
Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12431679
|
Duzova A et al. |
Triple immunosuppression with tacrolimus in pediatric renal transplantation: single-center experience. |
2008 Jan-Feb |
Transplant. Proc. |
pmid:18261567
|
Blume C et al. |
Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750357
|
Kuroki H et al. |
Morphological and immunological analysis of rats with long-term-surviving limb allografts induced by a short course of FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703697
|
White SA et al. |
Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10700949
|
Martins L et al. |
Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity? |
2004 |
Transplant. Proc. |
pmid:15194300
|
Busque S et al. |
Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636507
|